Laos is the most bombed country per capita in world history, but its spirit remains strong, and so does its food culture. In this video, we explore Laotian cuisine across cities, villages, and markets ...

Krispy Kreme (NASDAQ: DNUT) and GoPro were among the companies riding the latest meme stock rally on Wednesday as retail traders latched on to the highly shorted names, a day after piling into the ...

Get the latest Vanda Pharmaceuticals Inc. (VNDA) stock news and headlines to help you in your trading and investment decisions.

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Vanda (VNDA – Research Report) on February 14 and set a price target of $20.00. The company’s shares closed last Friday at $4. ...

Vanda Pharmaceuticals Inc (VNDA) reports strong Fanapt sales growth and strategic initiatives, despite facing increased competition and rising expenses.

Vanda's board of directors unanimously rejects the second takeover proposal from Cycle Group Holdings. Shares rise on the news.

VNDA’s upcoming pipeline features milsaperidone and tradipitant, with promising Phase III trials for new indications and long-acting injectables.

Vanda (VNDA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Vanda Pharma (NASDAQ:VNDA) just reported results for the first quarter of 2024. Vanda Pharma reported earnings per share of -7 cents. This was below the analyst estimate for EPS of 5 cents. The ...

On Vanda's (VNDA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its marketed drugs and certain pipeline and regulatory updates.